Equities

Panacea Biotec Ltd

PANACEABIO:NSI

Panacea Biotec Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)314.09
  • Today's Change-16.54 / -5.00%
  • Shares traded28.69k
  • 1 Year change+93.88%
  • Beta0.9732
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income1512814,488
Depreciation/depletion367391437
Non-Cash items(455)(1350)(14987)
Cash taxes paid, supplemental25254,037
Cash interest paid, supplemental26363,898
Changes in working capital72(3394)(1022)
Total cash from operations(1)(4225)(1084)
INVESTING
Capital expenditures(777)(409)(125)
Other investing and cash flow items, total8794,71312,951
Total cash from investing1024,30312,826
FINANCING
Financing cash flow items(26)(36)(3898)
Total cash dividends paid------
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(2.36)(148)(7861)
Total cash from financing(28)(184)(11759)
NET CHANGE IN CASH
Foreign exchange effects0.03(0.04)(0.13)
Net change in cash73(105)(17)
Net cash-begin balance/reserved for future use399504521
Net cash-end balance/reserved for future use472399504
SUPPLEMENTAL INCOME
Depreciation, supplemental367391437
Cash interest paid, supplemental26363,898
Cash taxes paid, supplemental25254,037
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.